CU23422B7 - Derivados de hidroxi-tetrahidro-naftalenilurea - Google Patents

Derivados de hidroxi-tetrahidro-naftalenilurea

Info

Publication number
CU23422B7
CU23422B7 CU20040254A CU20040254A CU23422B7 CU 23422 B7 CU23422 B7 CU 23422B7 CU 20040254 A CU20040254 A CU 20040254A CU 20040254 A CU20040254 A CU 20040254A CU 23422 B7 CU23422 B7 CU 23422B7
Authority
CU
Cuba
Prior art keywords
pain
derivatives
tetrahydro
useful
treatment
Prior art date
Application number
CU20040254A
Other languages
English (en)
Inventor
Yasuhiro Tsukimi
Masaomi Tajimi
Mashiro Shiroo
Toshiya Moriwaki
Hiroshi Fujishima
Klaus Urbahns
Tsutomu Masuda
Nagahiro Yoshida
Nuriyuki Yamamoto
Muneto Mogi
Toshio Kokubo
Takeshi Yura
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of CU23422B7 publication Critical patent/CU23422B7/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/40—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Esta invención se refiere a derivados de tetrahidro-naftaleno y a sales del mismo que son útiles como ingredientes activo de preparaciones farcéuticas. Los derivados de tetrahidro-naftaleno de la presente invención tienen una excelente actividad como antagonista de VR1 y es útil para la prevención y tratamiento de enfermedades relacianadas con la actividad de VR1, en particular para el tratamiento de incontinencia urinaria de urgencia , vejiga hiperactiva, dolor crónico, dolor neuropático, dolor postoperatorio, dolor por artritis reumatoide, neuralgia, neuropatías, algesia, lesión nerviosa, isquemia, neurodegeneración, apoplejía, incontinencia, trastornos inflamatorios, asma y COPD.
CU20040254A 2002-05-08 2004-11-04 Derivados de hidroxi-tetrahidro-naftalenilurea CU23422B7 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0210512.0A GB0210512D0 (en) 2002-05-08 2002-05-08 Tetrahydro-napthalene derivatives
GBGB0227262.3A GB0227262D0 (en) 2002-05-08 2002-11-21 Tetrahydro-naphthalene derivatives

Publications (1)

Publication Number Publication Date
CU23422B7 true CU23422B7 (es) 2009-09-08

Family

ID=9936269

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20040254A CU23422B7 (es) 2002-05-08 2004-11-04 Derivados de hidroxi-tetrahidro-naftalenilurea

Country Status (13)

Country Link
KR (1) KR101000688B1 (es)
AR (1) AR039983A1 (es)
CU (1) CU23422B7 (es)
DO (1) DOP2003000642A (es)
EC (1) ECSP045413A (es)
GB (2) GB0210512D0 (es)
GT (1) GT200300102A (es)
MA (1) MA30728B1 (es)
MY (1) MY155011A (es)
PE (1) PE20040363A1 (es)
PT (1) PT1506167E (es)
UA (1) UA77301C2 (es)
ZA (1) ZA200408993B (es)

Also Published As

Publication number Publication date
ZA200408993B (en) 2006-01-25
GB0210512D0 (en) 2002-06-19
MY155011A (en) 2015-08-28
PT1506167E (pt) 2007-12-10
UA77301C2 (en) 2006-11-15
DOP2003000642A (es) 2003-11-15
KR101000688B1 (ko) 2010-12-10
AR039983A1 (es) 2005-03-09
PE20040363A1 (es) 2004-07-03
KR20040108784A (ko) 2004-12-24
ECSP045413A (es) 2005-01-03
GB0227262D0 (en) 2002-12-31
MA30728B1 (fr) 2009-10-01
GT200300102A (es) 2004-03-17

Similar Documents

Publication Publication Date Title
ATE370118T1 (de) Tetrahydronaphtalen-derivate
DOP2013000105A (es) Derivados de 2,3-dihidroimidazo[1,2-c]quinazolina sustituidos con aminoalcoholes que son de utilidad para tratar trastornos hiperproliferativos y enfermedades asociadas a la angiogénesis
DE60315973D1 (de) Hydroxy-tetrahydro-naphtalenylharnstoff-derivate
AR058679A1 (es) Preparacion farmaceutica que contiene meloxicam
MX343215B (es) Composiciones farmacéuticas del compuesto espiro-oxindol para administración tópica y sus usos como agentes terapéuticos.
BR112014017780A8 (pt) Compostos de sulfona tricíclicos e métodos para fazer e usar os mesmos
BR112012025015A2 (pt) formulações farmacêuticas para tratamento de bexiga hiperativa.
AR040248A1 (es) Farmaco para el tratamiento de la vejiga hiperactiva
CL2008002747A1 (es) Compuestos derivados de furo y tienopirimidina; composicion farmaceutica; metodo para modular la actividad del receptor de histamina h4; y uso en el tratamiento de trastornos tales como inflamacion, trastornos alergicos, dermatologicos, entre otros.
WO2011056033A3 (ko) 장기 숙성 재래 간장에서 분리한 메일라드 펩타이드를 유효성분으로 함유하는 ｔｒｐｖ１ 활성 관련 질환 또는 염증 관련 질환의 예방 또는 치료용 약학적 조성물
CR20210686A (es) Análogos de 3–(5–metil–1,3–tiazol–2–il)–n–{(1r)–1–[2–(trifluor–metil)pirimidin–5–il]etil}benzamida
DK1572632T3 (da) Tetrahydro-naphthalenderivater som vanilloidreceptorantagonister
CL2024001231A1 (es) Formas cristalinas de derivados de quinazolina, preparación, composición y uso de estas
CU23422B7 (es) Derivados de hidroxi-tetrahidro-naftalenilurea
ATE442864T1 (de) Pharmazeutische zusammensetzung mit einem organopolysiloxan-elastomer und einem lösungsmittel-aktivwirkstoff
UY27794A1 (es) Derivados de hidroxi tetrahidro-naftalenilurea
CA3156118A1 (en) Intranasal pharmaceutical compositions of cyclobenzaprine
ITMI20031941A1 (it) Composizioni farmaceutiche topiche per il trattamento delle dermatiti
BR112013015489A2 (pt) combinação e composição para o tratamento de obesidade
EA201200753A1 (ru) Фармацевтическая композиция для лечения заболеваний мочевого пузыря
NO20064196L (no) Utvortes preparat for behandling av smertefulle hudskader
WO2012060594A3 (ko) 티오우레아계 화합물 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 함유하는 항염증 조성물
UA60688U (ru) Фармацевтическая композиция для лечения заболеваний органов дыхания и заболеваний аллергического типа
UY31669A1 (es) &#34;formulación farmacéutica que comprende oxabispidinas /236&#34;
DOP2004001047A (es) Derivados de cromano